BTIG Research restated their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a report issued on Monday, MarketBeat.com reports. They currently have a $18.00 target price on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. Jefferies Financial Group lowered their price target on shares of […]

BWX Technologies (NYSE:BWXT – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at BTIG Research in a report released on Wednesday, Benzinga reports. They presently have a $235.00 target price on the technology company’s stock. BTIG Research’s target price indicates a potential upside of 71.83% from the company’s current price. […]

Upstart (NASDAQ:UPST – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at BTIG Research in a research note issued to investors on Tuesday, Marketbeat reports. They currently have a $43.00 target price on the stock. BTIG Research’s target price indicates a potential upside of 75.87% from the company’s current price. Several […]